ScholarIQanswers from OpenAlex & ORCID
Dora Dias‐Santagata
ResearcherPublications, citations & collaboration network
Dora Dias‐Santagata is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Dora Dias‐Santagata have?
ScholarIQindexed works
Dora Dias‐Santagata has 359 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Dora Dias‐Santagata have?
ScholarIQcitation count
Dora Dias‐Santagata has 22,149 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Dora Dias‐Santagata?
ScholarIQh-index
Dora Dias‐Santagata has an h-index of 63 in OpenAlex.
What is the i10-index of Dora Dias‐Santagata?
ScholarIQi10-index
Dora Dias‐Santagata has an i10-index of 107 in OpenAlex.
What is the ORCID of Dora Dias‐Santagata?
ScholarIQorcid
The ORCID for Dora Dias‐Santagata is on the source record.
What is the OpenAlex record for Dora Dias‐Santagata?
ScholarIQopenalex
The OpenAlex for Dora Dias‐Santagata is on the source record.
What are the most-cited papers on Dora Dias‐Santagata?
ScholarIQmost cited works
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist, Belinda A. Waltman, Dora Dias‐Santagata, Subba R. Digumarthy, Alexa B. Turke, Panos Fidias, Kristin Bergethon, Alice T. Shaw, Scott Gettinger, Arjola K. Cosper, Sara Akhavanfard, Rebecca S. Heist, Jennifer S. Temel, James G. Christensen, John C. Wain, Thomas J. Lynch, Kathy Vernovsky, Eugene J. Mark, Michael Lanuti, A. John Iafrate, Mari Mino–Kenudson, Jeffrey A. Engelman
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer
Justin F. Gainor, Leila Dardaei, Satoshi Yoda, Luc Friboulet, Ignaty Leshchiner, Ryohei Katayama, Ibiayi Dagogo‐Jack, Shirish M. Gadgeel, Katherine R. Schultz, Manrose Singh, Emily Chin, Melissa Parks, Dana Lee, Richard H. DiCecca, Elizabeth L. Lockerman, Tiffany G. Huynh, Jennifer Logan, Lauren L. Ritterhouse, Long P. Le, Ashok Muniappan, Subba R. Digumarthy, Colleen L. Channick, Colleen Keyes, Gad Getz, Dora Dias‐Santagata, Rebecca S. Heist, Jochen K. Lennerz, Lecia V. Sequist, Cyril H. Benes, A. John Iafrate, Mari Mino–Kenudson, Jeffrey A. Engelman, Alice T. Shaw
EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of <i>BRAF</i> -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
Ryan B. Corcoran, Hiromichi Ebi, Alexa B. Turke, Erin M. Coffee, Michiya Nishino, Alexandria P. Cogdill, Ronald D. Brown, Patricia Della Pelle, Dora Dias‐Santagata, Kenneth E. Hung, Keith T. Flaherty, Adriano Piris, Jennifer A. Wargo, Jeffrey Settleman, Mari Mino–Kenudson, Jeffrey A. Engelman
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
Priscilla K. Brastianos, Amaro Taylor‐Weiner, Peter Manley, Robert T. Jones, Dora Dias‐Santagata, Aaron R. Thorner, Michael S. Lawrence, Fausto J. Rodríguez, Lindsay A. Bernardo, Laura Schubert, Ashwini Sunkavalli, Nick Shillingford, Monica L. Calicchio, Hart G.W. Lidov, Hala Taha, Maria Martinez‐Lage, Mariarita Santi, Phillip B. Storm, John Y. K. Lee, James N. Palmer, Nithin D. Adappa, R. Michael Scott, Ian F. Dunn, Edward R. Laws, Chip Stewart, Keith L. Ligon, Mai P. Hoang, Paul Van Hummelen, William C. Hahn, David N. Louis, Adam Resnick, Mark W. Kieran, Gad Getz, Sandro Santagata
<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
Nicolas Marcoux, Scott Gettinger, Grainne M. O’Kane, Kathryn C. Arbour, Joel W. Neal, Hatim Husain, Tracey L. Evans, Julie R. Brahmer, Alona Muzikansky, Philip Bonomi, Salvatore Del Prete, Anna Wurtz, Anna F. Farago, Dora Dias‐Santagata, Mari Mino–Kenudson, Karen L. Reckamp, Helena A. Yu, Heather A. Wakelee, Frances A. Shepherd, Zofia Piotrowska, Lecia V. Sequist